Evidence map›Paper›PMID 19793984›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2009

Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus.

Detlef Vullhorst, Jörg Neddens, Irina Karavanova, Ludovic Tricoire, Ronald S Petralia, Chris J McBain, Andres Buonanno

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 220 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Detlef VullhorstSection on Molecular Neurobiology, Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institute on Deafness and other Communication Disorders, Bethesda, Maryland 20892-3714, USA.
Jörg Neddens
Irina Karavanova
Ludovic Tricoire
Ronald S Petralia
Chris J McBain
Andres Buonanno
Institute of Neurobiology and Molecular Medicine · ITEunice Kennedy Shriver National Institute of Child Health and Human Development · USNational Institute on Deafness and Other Communication Disorders · US

Funding

Cellular And Synaptic Physiology Of Hippocampal InterneuronsZIAHD001205 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MCBAIN, CHRIS J. · 2009 to 2025
$45.8M
Neuregulin-ErbB Signaling in Neuronal Development and Psychiatric DisordersZIAHD000711 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI BUONANNO, ANDRES · 2009 to 2024
$24.4M
Molecular Mechanisms Of Synaptic TransmissionZIADC000003 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI ROBINSON, DAVID · 2009 to 2012
$6.3M
TRANSCRIPTION REGULATION OF SYNAPSE-SPECIFIC GENES IN SKELETAL MUSCLEZ01HD000711 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI BUONANNO, ANDRES · 1990 to 2008
$2.4M
Intramural NIH HHS Z01 HD000711Intramural NIH HHS ZIA HD000711
6 · The paper itself

Abstract

NRG1 and ERBB4 have emerged as some of the most reproducible schizophrenia risk genes. Moreover, the Neuregulin (NRG)/ErbB4 signaling pathway has been implicated in dendritic spine morphogenesis, glutamatergic synaptic plasticity, and neural network control. However, despite much attention this pathway and its effects on pyramidal cells have received recently, the presence of ErbB4 in these cells is still controversial. As knowledge of the precise locus of receptor expression is crucial to delineating the mechanisms by which NRG signaling elicits its diverse physiological effects, we have undertaken a thorough analysis of ErbB4 distribution in the CA1 area of the rodent hippocampus using newly generated rabbit monoclonal antibodies and ErbB4-mutant mice as negative controls. We detected ErbB4 immunoreactivity in GABAergic interneurons but not in pyramidal neurons, a finding that was further corroborated by the lack of ErbB4 mRNA in electrophysiologically identified pyramidal neurons as determined by single-cell reverse transcription-PCR. Contrary to some previous reports, we also did not detect processed ErbB4 fragments or nuclear ErbB4 immunoreactivity. Ultrastructural analysis in CA1 interneurons using immunoelectron microscopy revealed abundant ErbB4 expression in the somatodendritic compartment in which it accumulates at, and adjacent to, glutamatergic postsynaptic sites. In contrast, we found no evidence for presynaptic expression in cultured GAD67-positive hippocampal interneurons and in CA1 basket cell terminals. Our findings identify ErbB4-expressing interneurons, but not pyramidal neurons, as a primary target of NRG signaling in the hippocampus and, furthermore, implicate ErbB4 as a selective marker for glutamatergic synapses on inhibitory interneurons.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsCells, CulturedErbB Receptorsgamma-Aminobutyric AcidHippocampusInterneuronsMaleMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsPyramidal CellsRabbitsRatsRats, Sprague-DawleyERBB4 protein, humanErbb4 protein, mouseErbb4 protein, ratErbB Receptorsgamma-Aminobutyric AcidReceptor, ErbB-4

Identifiers

PMID19793984
PMCPMC2774835
OpenAlexW2023823207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.